Literature DB >> 7249435

The Ommaya reservoir in chemotherapy for malignant disease in the CNS.

A Jacobs, P Clifford, H E Kay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7249435

Source DB:  PubMed          Journal:  Clin Oncol        ISSN： 0305-7399


× No keyword cloud information.
  8 in total

1.  Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model.

Authors:  David I Sandberg; Juan Solano; Carol K Petito; Abdul Mian; Caihong Mou; Tulay Koru-Sengul; Manuel Gonzalez-Brito; Kyle R Padgett; Ali Luqman; Juan Carlos Buitrago; Farid Alam; Jerome R Wilkerson; Kenneth M Crandall; John W Kuluz
Journal:  J Neurooncol       Date:  2010-05-04       Impact factor: 4.130

2.  Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.

Authors:  Masahide Matsuda; Keisuke Nimura; Takashi Shimbo; Toshimitsu Hamasaki; Tetsuya Yamamoto; Akira Matsumura; Yasufumi Kaneda
Journal:  J Neurooncol       Date:  2010-08-22       Impact factor: 4.130

3.  Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device.

Authors:  R de Waal; P R Algra; J J Heimans; J G Wolbers; P Scheltens
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

Review 4.  Pharmacokinetics of the carmustine implant.

Authors:  Alison B Fleming; W Mark Saltzman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model.

Authors:  David I Sandberg; Kenneth M Crandall; Tulay Koru-Sengul; Kyle R Padgett; John Landrum; Darwin Babino; Carol K Petito; Juan Solano; Manuel Gonzalez-Brito; John W Kuluz
Journal:  J Neurooncol       Date:  2009-08-18       Impact factor: 4.130

6.  Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies.

Authors:  D J Stewart; J A Maroun; H Hugenholtz; B Benoit; A Girard; M Richard; N Russell; L Huebsch; J Drouin
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

7.  Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.

Authors:  David I Sandberg; Michael Rytting; Wafik Zaky; Marcia Kerr; Leena Ketonen; Uma Kundu; Bartlett D Moore; Grace Yang; Ping Hou; Clark Sitton; Laurence J Cooper; Vidya Gopalakrishnan; Dean A Lee; Peter F Thall; Soumen Khatua
Journal:  J Neurooncol       Date:  2015-08-09       Impact factor: 4.130

8.  Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical note.

Authors:  David I Sandberg; Marcia L Kerr
Journal:  Childs Nerv Syst       Date:  2015-11-23       Impact factor: 1.475
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.